MICROMET
| WVB Number : USA000035678 | Country : United States of America |
| SIC categorization : BIOLOGICAL PDS,EX DIAGNSTICS (2836) | ISIN : US59509C1053 |
| FT categorization : DIV'D HEALTH & PERSONAL CARE (430) | |
| Company status: ACTIVE |
» Corporation Profile :
| Profile in brief: The Company, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibodies for the treatment of cancer, inflammation, and autoimmune diseases. |
|
| Phone : 1 240 752 1420 | Fax : 240 752 1425 |
| Chairman: : CHRISTIAN ITIN | Auditor : ERNST & YOUNG AG WIRTSCHAFTSPRÜFUNGSGESELLSCHAFT STEUERBERATUNGSGESELLSCHAFT |
| CEO/Managing Director : CHRISTIAN ITIN | |
» Company Facts
| Net Profit Margin (%) | -155.69 |
| Operating Margin (%) | -155.31 |
| Return on Assets (%) | -23.73 |
| Return on Equity (%) | -37.07 |
| Employees | 192 |
» Company Financials
| Annual (2010) | |
| Income Statement ('000 USD ) |
|
| Sales/Total Revenue | 28,744 |
| EBITDA | -39,118 |
| EBIT | -41,384 |
| Net Income | -44,751 |
| Balance Sheet ( '000 USD) |
|
| Total Current Assets | 225,864 |
| Total Assets | 242,304 |
| Current Liabilities | 46,017 |
| Total Liabilities & Debt | 67,715 |
| Total Equity | 174,589 |
| Cash & Flow ( '000 USD) |
|
| Net Income/Staring Line | -44,751 |
| Cash from Operating | -35,086 |
| Cash from Investing | -126,224 |
| Cash from Financing | 147,449 |
| Cash & Equivalent Yr End | 220,967 |